Prothrombin Time Reagent Recalled for Quality Control Failures
Instrumentation Laboratory is recalling HemosIL ReadiPlasTin due to variable and out-of-specification quality control results. The manufacturer is removing all affected lots and providing customers with an alternative reagent.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II medical device recall with quality control failures affecting product performance. No illnesses or injuries reported; the hazard is potential rather than confirmed, meeting the criterion of 'risk-of-harm product where injury has not yet been reported.'
Plain-English summary
Instrumentation Laboratory is recalling HemosIL ReadiPlasTin (Part No. 0020301400), a reagent used in prothrombin time testing, a common blood coagulation test performed in clinical and hospital laboratories.
The recall was initiated due to variable and out-of-specification quality control results detected in affected lots. While no illnesses or injuries have been reported, these QC failures could affect the accuracy and reliability of prothrombin time test results.
The recall affects 1,563 units distributed across the United States, including Arizona, California, Iowa, Illinois, Indiana, Kansas, Maryland, Maine, Michigan, Minnesota, Missouri, North Carolina, Nebraska, New York, Ohio, Oklahoma, South Carolina, Texas, Virginia, and West Virginia. All in-date lots identified by UDI 08426950632887 are included in the recall. Instrumentation Laboratory is working with affected customers to remove the product from use and transition them to HemosIL RecombiPlasTin 2G, an alternative prothrombin time reagent.
The recalled product
- Product
- HemosIL ReadiPlasTin, Part No. 0020301400
- Manufacturer
- Instrumentation Laboratory
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- UDI 08426950632887 All in-date lots are affected by this recall.
Distribution
Related recalls
Same manufacturer · Instrumentation Laboratory
See all →- SevereGEM Premier 5000 PAK Lysing Solution Concentration Recall
FDA (Devices) · 2026-08-12
- HighGEM Premier 7000 with iQM3 Blood Analysis Systems Recalled for Solution Concentration Issues
FDA (Devices) · 2026-08-12
- HighPortable Blood Analyzer System Recalled Due to Barcode Reader Misidentification Risk
FDA (Devices) · 2026-08-05
- HighBar Code Reader Wands for GEM Premier Blood Analyzers Recalled Due to Misidentification Risk
FDA (Devices) · 2026-08-05
- HighBlood Analyzer Bar Code Reader May Assign Patient Results to Incorrect Patient ID
FDA (Devices) · 2026-08-05
Same hazard · qc failure
See all →- HighHelix Elite Quality Control Material Recalled for Delayed Detection and QC Failure
FDA (Devices) · 2025-04-02
- HighBD BBL Sensi Disc Cefixime Antibiotic Susceptibility Test Accuracy Failures
FDA (Devices) · 2024-02-14
- HighAntibiotic susceptibility test discs recalled for accuracy and quality failures
FDA (Devices) · 2024-02-14
- HighBD BBL Sensi Disc Meropenem testing discs recalled for accuracy failures
FDA (Devices) · 2024-02-14
- HighAntibiotic Susceptibility Test Discs Recalled for Accuracy and QC Failures
FDA (Devices) · 2024-02-14